Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients

In a nonblind, randomised, parallel-group study, initial empirical monotherapy with meropenem 1 g intravenously every 8 h was compared to an identical dosage of imipenem/cilastatin for the treatment of 66 febrile episodes in 61 adult neutropenic patients. 25/31 episodes treated with meropenem and 24...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection 1996-11, Vol.24 (6), p.480-484
Hauptverfasser:	SHAH, P. M, HELLER, A, STILLE, W, FUHR, H.-G, WALTHER, F, HALIR, S, SCHAUMANN, R, BÖHME, A, JUNG, B, KÖHLER, A, LIPS-SCHULTE, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Cilastatin - therapeutic use Cilastatin, Imipenem Drug Combination Drug Combinations Drug Therapy, Combination - therapeutic use Female Fever - drug therapy Fever - microbiology Humans Imipenem - therapeutic use Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infusions, Intravenous Leukocyte Count Male Medical sciences Meropenem Middle Aged Neutropenia - complications Thienamycins - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!